ClinicalTrials.gg
TerminatedNCT04002726Updated Aug 22, 2022

App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders

An interventional study of Inter-grader agreement (IGA) app in Trachoma, sponsored by London School of Hygiene and Tropical Medicine. Terminated at 1 site in Tanzania. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-08-22.

Sponsored by London School of Hygiene and Tropical Medicine · Not applicable, Interventional, and Other

Why this study was terminated
Lack of funding
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Trachomatous inflammation-follicular (TF) is diagnosed by looking for clinical signs of infection of everted eyelids (conjunctivae) of children.

The overall objective of this project is to investigate the effectiveness, acceptability and feasibility of an app-based versus slide-based IGA for trachoma graders.

Fieldwork will take place during routine Tropical Data trainings. A non-inferiority randomised controlled trial design will be employed, with grader trainees randomised to app- or slide-based training, and then to app- or slide-based IGA testing. The training and IGA testing method will be compared with field IGA test score to determine which method best predicts passing the field IGA test.

Read the detailed description

Trachoma graders are currently trained using either slide- or app-based testing systems. The investigators want to formally assess whether the app-based training and testing system leads to better field-based diagnosis than the slide-based training and testing system. The investigators will also ask participants for their views on acceptability of the two systems and conduct a cost-consequences analysis of the two systems.

Objectives and approach:

1.1 To compare the two classroom IGA tests (app-based and slides-based) in terms of their ability to predict trainee success in the field IGA test.

1.2 To assess whether the kappa score threshold for the classroom IGA tests is appropriate.

1.3 To conduct a cost-consequences analysis of the training systems in order to effectively target the use of an app-based assessment and training system.

1.4 To investigate whether grader trainee characteristics have an impact on trainee performance in the IGA tests.

1.5 To obtain feedback on the app-based system's usability and acceptability. 1.6 To compare the two classroom IGA training methods (app-based and slides-based) in terms of classroom IGA test (app-based and slides-based) outcome and field IGA test outcome.

02

Conditions studied

  • Trachoma

Browse trials for

03

In context

Trachoma

39 studies on the registry are indexed under Trachoma; 3 are open to participants now.

This study's enrollment of 32 is below the median of 1,300 across 31 interventional studies indexed under Trachoma.

Browse Trachoma studies →

Lead sponsor

London School of Hygiene and Tropical Medicine is the lead sponsor of 298 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All trainers and trainee graders who attend selected Tropical Data training events will be eligible for inclusion in the study.

Exclusion criteria

Exclusion Criteria:

  • Individuals who do not provide consent are not eligible for inclusion in the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    Group Aa

    Allocated to do the app-based training. Allocated to do the app-based classroom IGA test first, and the slide-based test second.

    Other: Inter-grader agreement (IGA) app

  • Active comparator
    Group As

    Allocated to do the app-based training. Allocated to do the slide-based classroom IGA test first, and the app-based test second.

    Other: Inter-grader agreement (IGA) app

  • Active comparator
    Group Sa

    Allocated to do the slide-based training. Allocated to do the app-based classroom IGA test first, and the slide-based test second.

    Other: Inter-grader agreement (IGA) app

  • Active comparator
    Group Ss

    Allocated to do the app-based training. Allocated to do the slide-based classroom IGA test first, and the app-based test second.

    Other: Inter-grader agreement (IGA) app

Interventions

  • OtherInter-grader agreement (IGA) app

    A smartphone-based app with images of conjunctivae for trachoma grading training purposes.

06

What researchers measure

Primary outcomes

  1. Classroom IGA success

    The proportion of participants successfully passing (kappa ≥0.7) the app-based IGA.

    Time frame: 1 day

  2. Classroom IGA success

    The proportion of participants successfully passing (kappa ≥0.7) the slide-based IGA.

    Time frame: 1 day

  3. Field IGA success

    The correlation between classroom IGA score and field IGA score

    Time frame: 3 days

  4. Field IGA success

    The proportion of participants who successfully pass the classroom IGA test (kappa ≥0.7) who also successfully pass the field-based IGA test (kappa ≥0.7)

    Time frame: 3 days

Secondary outcomes

  1. Trainee characteristics

    Association (reported as proportions, unadjusted and adjusted odds ratios) between trainee characteristics and the probability of successfully passing classroom IGA test

    Time frame: 5 days

  2. Trainee characteristics

    Association (reported as proportions, unadjusted and adjusted odds ratios) between trainee characteristics and the probability of successfully passing the field IGA test

    Time frame: 5 days

  3. Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based training.

    Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of app versus slide-based training.

    Time frame: 45 minutes

  4. Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based IGA testing.

    Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of app versus slide-based IGA testing.

    Time frame: 45 minutes

  5. Cost of app versus slide-based training

    Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of app versus slide-based training

    Time frame: 5 days

  6. Cost of app versus slide-based IGA testing

    Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of app versus slide-based IGA testing

    Time frame: 5 days

07

Study locations

1 site
  • Arusha region
    Arusha, Tanzania
08

References and documents

Individual participant data

Plan to share: Yes — Anonymised data will be shared with relevant study team members for the purposes of data analysis. Data Transfer Agreements will be completed, where appropriate.

Supporting information: Study protocol

Time frame: Data will be shared with team members as they are collected.

Access criteria: Data access requests from outside the study team for the specified data analyses will be reviewed by the Principal Investigator. Requestors will be required to sign a Data Access Agreement.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04002726
Collaborators
National Institute for Medical Research, Tanzania, Federal Minstry of Health of Ethiopia, Jos University Teaching Hospital, University College London Hospitals, RTI International, Sightsavers, World Health Organization, Pan American Health Organization
Responsible party
Sponsor
First posted
Jul 1, 2019
Start date
Jul 8, 2019
Primary completion
Jul 12, 2019
Completion
Jul 12, 2019
Last update
Aug 22, 2022

Study contacts

Emma Harding-Esch
principal investigator · London School of Hygiene and Tropical Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion